Monday, 18 July 2011 09:00

GE Healthcare Launches IN Cell Analyzer Compliance Management Solution

GE Healthcare’s IN Cell Analyzer Compliance Manager is designed to aid GxP compliance of the IN Cell Analyzer 2000 system.

IN Cell Analyzer 2000 is a high content cellular analysis (HCA) system, a powerful technique for high throughput microscopic analysis of cells which allows deeper insights into cellular behavior whilst improving productivity.

IN Cell Analyzer Compliance Manager is a software module for the IN Cell Analyzer 2000 that brings both operating and analysis software to a 21 CFR Part 11 compliant standard. Developed to facilitate compliance with regulatory expectations worldwide, IN Cell Analyzer Compliance Manager is the first 21 CFR Part 11 compliant software from GE Healthcare for high-content analysis, and delivers required functionality such as:

  • Role based user authorization levels to set access rights
  • Published procedures for operational control that lock run and evaluation settings together
  • Audit trails to record modifications and maintain histories on procedures
  • Data integrity and Certificate of Audit

GxP instrument validation services are also available using a risk-based validation approach, to demonstrate compliance and fitness for intended use throughout the equipment’s working life. GxP Validation Services are carried out exclusively by GE Healthcare’s trained service personnel and enable a system to be validated before use and periodically re-evaluated throughout the working life of the instrument.

For further information please visit www.gelifesciences.com/incell

Read 4081 times Last modified on Tuesday, 31 January 2012 13:48

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

Want more? Visit...

Videos

  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses the launch of ICON's new acquisition of Firecrest at Partnerships in Clinical Trials 2012. Facing the continuing challenge of not only monitoring and…
    Read more...
  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses their exciting new partnership with Roche at Partnerships In Clinical Trials 2012. Medical imaging has always been a strong department within ICON. ICON…
    Read more...
  • ERT- Partnerships 12
    ERT- Partnerships 12 John Blakely, Executive Vice President and Chief Commercial Officer for ERT discusses the new trend in clinical research at Partnerships in Clinical Trials 2012 - the melding of objective and…
    Read more...
  • Chiltern- Partnerships 12
    Chiltern- Partnerships 12 Marcelo Piccirillo, Senior Clinical Research Physician for Chiltern, discusses new trends in gastrointestinal clinical development at Partnerships in Clinical Trials 2012. Current hot spots for clinical development in the field…
    Read more...
  • Blinded Diagnostics - Partnerships 12
    Blinded Diagnostics - Partnerships 12 Paul Savuto, President and CFO, and Steven Karrupan, CEO, from Blinded Diagnostics discuss Point of Care Technology at Partnerships in Clinical Trials 2012. Point of care (or decentralized testing) offers…
    Read more...
  • American Airlines - IQPC 2011
    American Airlines - IQPC 2011 American Airlines has globally launched a passive solutions that gives a new alternative to pharmaceutical manufacturers.
    Read more...

Podcasts